Publicaciones en las que colabora con SERGIO MARTINEZ HERVAS (92)

2022

  1. A Very Rare Variant in SREBF2, a Possible Cause of Hypercholesterolemia and Increased Glycemic Levels

    Biomedicines, Vol. 10, Núm. 5

  2. Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity

    Microvascular Research, Vol. 139

  3. Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players

    Biomedicine and Pharmacotherapy, Vol. 145

  4. Corticotroph cell hyperplasia as a rare cause of ACTH-dependent Cushing syndrome

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 694-701

  5. Developing a simple and practical decision model to predict the risk of incident type 2 diabetes among the general population: The Di@bet.es Study

    European Journal of Internal Medicine, Vol. 102, pp. 80-87

  6. Effect of personality on blood glucose control in patients with type 1 diabetes

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 9, pp. 677-685

  7. Estándares SEA 2022 para el control global del riesgo cardiovascular

    Clínica e investigación en arteriosclerosis, Vol. 34, Núm. 3, pp. 130-179

  8. Guided clinical case as a methodology for learning: experience in the subject of endocrinology and nutrition in the medical degree

    EDULEARN22 Proceedings: 14th International Conference on Education and New Learning Technologies : July 4th-6th, 2022

  9. SEA 2022 Standards for Global Control of Cardiovascular Risk

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 3, pp. 130-179

2020

  1. Dapagliflozin does not modulate atherosclerosis in mice with insulin resistance

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-18

  2. Easy One-Step Amplification and Labeling Procedure for Copy Number Variation Detection

    Clinical chemistry, Vol. 66, Núm. 3, pp. 463-473